What is ANNX's current stock price?

As of now, ANNX is trading at $4.27, with a daily change of 0.00%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ANNX Stock Analysis & IQ Rating | Annexon

ANNX

Annexon

$4.27

-$0.00 | 0.00%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$5.65

MKT CAP

$618.66M

52W Low

$1.29

VOL

$3.17M

P/E Ratio

N/A

AVG VOL

$2.56M

RSI

74.02

TREND

Uptrend

ANNX Stock IQ

Login to see Annexon (ANNX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ANNX Target Price

Login to display

Strengths

ANNX Rewards

Upgraded on attractively valued

Chart

$3.45 (+23.77%)

$2.06 (+107.28%)

$2.89 (+47.75%)

$0.46 (+828.26%)

1year

6month

3month

1month

ANNX Risk Level

ANNX has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Extreme

LOW

HIGH

ANNX Analysts Opinion

ANNX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ANNX Analysts Opinion

ANNX Analysts opinion is negative but has improved from the past 3 months

ANNX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

NA

ANNX Street Sentiment

ANNX Street Sentiment is extremely bullish and have negative views on the near-term outlook

ANNX Performance Sentiment

Sentiments overview associated with ANNX events and the stock performance.

86%

10%

Positive

Negative

18 out of 21
events present

2 out of 21
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$4.27

Resistance
Price

$2.68

Current Price Range

$4.27

Show methods +

Linked to ANNX

IQ

Close Price

Change

NVS

4.27

127.31

+2.42%

JNJ

4.09

203.90

+0.51%

BLTE

3.66

120.56

+10.42%

ANNX Latest Analysis +

Annexon: Maintaining Buy Rating On Second C1q Inhibitor Advancement For Geographic Atrophy.

Thu Nov 20, 2025

$4.27 | +5.17%

Rating

Annexon stock rises after director purchases shares.

Thu Nov 20, 2025

$4.27 | +5.17%

Activity

Momentum

Thursday 11/20 Insider Buying Report: ANNX TH. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Wednesday Annexons Muneer A. Satter made a $5.06M purchase of ANNX buying

Thu Nov 20, 2025

$4.27 | +5.17%

Activity

Momentum

Wells Fargo Maintains Annexon (ANNX) Overweight Recommendation. Fintel reports that on November 19 2025 Wells Fargo maintained coverage of Annexon (NasdaqGS:ANNX) with a Overweight recommendation. Analyst Price Forecast Suggests 263.38% Upside

Wed Nov 19, 2025

$4.06 | +26.87%

Rating

Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight. Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape |. DelveInsightThe overall dry AMD market size in the US is anticipated to increase due to the uptake of recently approved therapies the launch of emerging therapies such as Gildeuretinol (Alkeus

Mon Nov 17, 2025

$3.02 | +11.44%

Activity

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants. ) a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body brain and eye today announced the pricing of its previously announced underwritten public offering of 25096153 shares of its common stock at a price to the public of $2.60 per share and in lieu of shares of common stock to certain investors

Thu Nov 13, 2025

$2.68 | -5.63%

Activity

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants. ) a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body brain and eye today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock or pre-funded warrants to purchase shares of its common stock in lieu thereof. All of the securities are being offered by Anne

Wed Nov 12, 2025

$2.84 | -4.38%

Activity

Annexon launches $75M public offering of common stock.

Wed Nov 12, 2025

$2.84 | -4.38%

Activity

Annexon stock falls after $75 million public offering announcement.

Wed Nov 12, 2025

$2.84 | -4.38%

Activity

Momentum

FAQ About ANNX Stock Insights

What is ANNX current stock price?

What are ANNX stock strengths?

What is ANNX Risk Level?

What is ANNX market cap and volume?

What is ANNX current Stock IQ?

Should I buy ANNX stock right now?

Is ANNX a Strong Buy right now?

What does a 'Strong Buy' rating mean for ANNX?

What does a 'Strong Sell' rating mean for ANNX?

What factors influence ANNX's Stock IQ?

Explore our ANNX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ANNX Stock Strategies
Effective Risk Management

FIND US ON

Receive our ANNX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ANNX

Annexon

Current Price

$4.27

-$0.00 | 0.00%

52W High

$5.65

MKT CAP

$618.66M

52W Low

$1.29

VOL

$3.17M

P/E Ratio

N/A

AVG VOL

$2.56M

RSI

74.02

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ANNX Rewards

Upgraded on attractively valued

Linked to ANNX

Symbol

IQ

Close

Change

NVS

4.27

127.31

+2.42%

JNJ

4.09

203.90

+0.51%

BLTE

3.66

120.56

+10.42%

ANNX Stock IQ

Login to unlock Annexon (ANNX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$3.45 (+23.77%)

$2.06 (+107.28%)

$2.89 (+47.75%)

$0.46 (+828.26%)

1year

6month

3month

1month

ANNX Analysts Opinion

ANNX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ANNX Analysts Opinion

ANNX Analysts opinion is negative but has improved from the past 3 months

ANNX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

86%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

NA

ANNX Street Sentiment

ANNX Street Sentiment is extremely bullish and have negative views on the near-term outlook

ANNX Risk Level

ANNX has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Extreme

LOW

HIGH

ANNX Performance Sentiment

Sentiments overview associated with ANNX events and the stock performance.

86%

10%

Positive

Negative

18 out of 21
events present

2 out of 21
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$4.27

Resistance
Price

$2.68

Current Price Range

$4.27

Show methods +

ANNX Latest Analysis

Annexon: Maintaining Buy Rating On Second C1q Inhibitor Advancement For Geographic Atrophy.

Thu Nov 20, 2025

$4.27 | +5.17%

Rating

Annexon stock rises after director purchases shares.

Thu Nov 20, 2025

$4.27 | +5.17%

Activity

Momentum

Thursday 11/20 Insider Buying Report: ANNX TH. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Wednesday Annexons Muneer A. Satter made a $5.06M purchase of ANNX buying

Thu Nov 20, 2025

$4.27 | +5.17%

Activity

Momentum

Wells Fargo Maintains Annexon (ANNX) Overweight Recommendation. Fintel reports that on November 19 2025 Wells Fargo maintained coverage of Annexon (NasdaqGS:ANNX) with a Overweight recommendation. Analyst Price Forecast Suggests 263.38% Upside

Wed Nov 19, 2025

$4.06 | +26.87%

Rating

Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight. Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape |. DelveInsightThe overall dry AMD market size in the US is anticipated to increase due to the uptake of recently approved therapies the launch of emerging therapies such as Gildeuretinol (Alkeus

Mon Nov 17, 2025

$3.02 | +11.44%

Activity

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants. ) a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body brain and eye today announced the pricing of its previously announced underwritten public offering of 25096153 shares of its common stock at a price to the public of $2.60 per share and in lieu of shares of common stock to certain investors

Thu Nov 13, 2025

$2.68 | -5.63%

Activity

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants. ) a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body brain and eye today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock or pre-funded warrants to purchase shares of its common stock in lieu thereof. All of the securities are being offered by Anne

Wed Nov 12, 2025

$2.84 | -4.38%

Activity

Annexon launches $75M public offering of common stock.

Wed Nov 12, 2025

$2.84 | -4.38%

Activity

Annexon stock falls after $75 million public offering announcement.

Wed Nov 12, 2025

$2.84 | -4.38%

Activity

Momentum

Discover ANNX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ANNX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ANNX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ANNX Stock trends

ANNX Stock performance

ANNX Stock analysis

ANNX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

ANNX Stock Analysis & IQ Rating | Annexon

ANNX Stock IQ

ANNX Target Price

ANNX Risk Level

ANNX Analysts Opinion

ANNX Street Sentiment

ANNX Performance Sentiment

Technical Price Levels

Explore our ANNX Stock insights

Receive our ANNX Daily Alerts

ANNX Stock IQ

ANNX Street Sentiment

ANNX Risk Level

Technical Price Levels

Discover ANNX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ANNX. We're here to help you make informed investment decisions today.

Receive our ANNX Daily Alerts

ANNX Runner Alarm